Liver cirrhosis is a risk-factor for Pneumocystis jirovecii associated mortality.

ABSTRACT:

Background

Pneumocystis jirovecci pneumonia (PCP) is a life threating disease in immunodeficient patients. Liver cirrhosis itself can lead to immunodefiency, however little is known if Pneumocystis jirovecci infection affects the outcome of patients with liver cirrhosis.

Aim

We aimed to assess the predictors for Pneumocystis jirovecci-associated mortality in patients with Pneumocystis jirovecci infection treated at intensive care units.

Methods

A total of 151 patients hospitalized between January 2013 and November 2019 with a PCR-confirmed Pneumocystis jirovecci infection were retrospectively included in this study and analysed for clinical predictors for PCJ associated mortality.

Results

The overall mortality in our patient cohort was 60%. Out of 151 patients

SUBMITTER: Peschel G 

PROVIDER: S-EPMC11496259 | biostudies-literature | 2024

REPOSITORIES: biostudies-literature